Birdwatch Note Rating
2024-01-23 01:58:33 UTC - HELPFUL
Rated by Participant: 13B42494BF29CA1094BE5EF3C37799854C1BDEA58ABE6AD926E3AF6A18EB4AB4
Participant Details
Original Note:
This news, from November, pertains to a gene therapy treatment for a type of cancer (not COVID-19). The FDA press release specifically notes the benefits of the treatment continue to outweigh the risks. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-investigating-serious-risk-t-cell-malignancy-following-bcma-directed-or-cd19-directed-autologous
All Note Details